Tour de Cure no more: BC Cancer Foundation ending prominent fundraiser
CTV
Citing declining revenue, rising costs and "increasing external risks," the BC Cancer Foundation announced Tuesday that it is ending its annual cycling fundraiser, the Tour de Cure.
Citing declining revenue, rising costs and "increasing external risks," the BC Cancer Foundation announced Tuesday that it is ending its annual cycling fundraiser, the Tour de Cure.
"The decision to end the Tour de Cure was extremely difficult," said Sarah Roth, the foundation's president and CEO, in a news release.
"As both the CEO and a nine-year rider myself, I understand the deep, personal connection our community has to this annual fundraising event. It has been a powerful symbol of hope and determination."
Formerly known as the Ride to Conquer Cancer, the tour began 16 years ago in 2009. Since then, it has raised more than $131 million in gross revenue, according to BC Cancer.
The foundation cited three "primary factors" for its decision to end the fundraiser. Those factors are:
Thousands of riders have participated in the fundraiser over the years, and Roth thanked them for their efforts in Tuesday's release.
"We are so grateful for the incredible contributions made by our riders, donors, volunteers, sponsors, and staff since our first ride in 2009," she said. "Your dedication has fuelled advances in cancer research and enhancements to care. The Tour de Cure has created a strong and supportive legacy as we move forward in our mission to achieve a world free from cancer."
